Showing results (41-50 of 83) with videos related to

Sort By:
Pageof 9
JAMA Oncology|September 22, 2022
Association of QTc Formula With the Clinical Management of Patients With CancerDaniel R Richardson, P Christopher Parish, Xianming Tan, et al.
Circulation Research|December 25, 2018
Adrenomedullin Induces Cardiac Lymphangiogenesis After Myocardial Infarction and Regulates Cardiac Edema Via Connexin 43Claire E Trincot, Wenjing Xu, Hua Zhang, et al.
American Heart Journal|September 18, 2012
Epidemiology, management, and outcomes of sustained ventricular arrhythmias after continuous-flow left ventricular assist device implantationHannah Raasch, Brian C Jensen, Patricia P Chang, et al.
Plos Biology|February 20, 2010
BIN1 localizes the L-type calcium channel to cardiac T-tubulesTing-Ting Hong, James W Smyth, Danchen Gao, et al.
Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquee, Nutrition Et Metabolisme|March 12, 2019
Two weeks of lower body resistance training enhances cycling tolerability to improve precision of maximal cardiopulmonary exercise testing in sedentary middle-aged femalesChad W Wagoner, Erik D Hanson, Eric D Ryan, et al.
Metabolites|June 23, 2017
Non-Targeted Metabolomics Analysis of the Effects of Tyrosine Kinase Inhibitors Sunitinib and Erlotinib on Heart, Muscle, Liver and Serum Metabolism In VivoBrian C Jensen, Traci L Parry, Wei Huang, et al.
The American Journal of Pathology|November 21, 2017
Clinical Evidence Supports a Protective Role for CXCL5 in Coronary Artery DiseaseSaranya Ravi, Robert N Schuck, Eleanor Hilliard, et al.
Breast Cancer Research and Treatment|April 26, 2017
Early cardiac perfusion defects after left-sided radiation therapy for breast cancer: is there a volume response?Orit Kaidar-Person, Timothy M Zagar, Jorge Daniel Oldan, et al.
World Journal of Clinical Oncology|June 30, 2021
Impact of community-based exercise program participation on aerobic capacity in women with and without breast cancerJordan T Lee, Chad W Wagoner, Stephanie A Sullivan, et al.
British Journal of Pharmacology|October 5, 2017
Effects of the kinase inhibitor sorafenib on heart, muscle, liver and plasma metabolism in vivo using non-targeted metabolomics analysisBrian C Jensen, Traci L Parry, Wei Huang, et al.
Pageof 9